Stifterverband für die Deutsche Wissenschaft / Simon-Claussen-Stiftung
Simon-Claussen-Stiftung Junior Professorship for Arteriosclerosis and Angiogenesis in renal failure (M Brand, 2007 – 2013)

Deutsche Gesellschaft für Nephrologie (DGfN)
Forschungsstipendium der DGfN: “Die Bedeutung von sFlt-1 für das renale und kardiovaskuläre remodelling in der chronischen Nierenerkrankung“ (GS Di Marco, 2012)

Deutsche Forschungsgemeinschaft (DFG)
DGF: “Soluble Flt-1 in chronic kidney disease: sites of production, regulation and direct effects on heart vascularization in the rat 5/6 nephrectomy model” (M Brand/Di Marco, 2011 – 2013)
DFG/SFB656 (Rotationsstelle): „Untersuchung des renokardialen Syndroms bei Kleintieren mittels MR” (M Brand/S Reuter, 2011 - 2012)


Else-Kröner-Fresenius-Stiftung (EKFS)
EKFS: “Cellular therapy with bone marrow-derived cells in chronic kidney disease-associated heart injury” (GS Di Marco/M Brand), 2013 – 2016)
EKFS: “Cardiovascular disease in an animal model of kidney disease: the role of soluble vascular endothelial growth factor receptor 1 (sFlt1) and calcineurin inhibitors” (M Brand/GS Di Marco, 2009 – 2011)

Innovative Medizinische Forschung (IMF - MFM): "Elevated sFlt-1 levels after renal ischemia-reperfusion injury: regulations and implications" (GS Di Marco, 2014 - 2017)
Innovative Medizinische Forschung (IMF – MFM): “Diabetes and Angiogenesis: different responses to endothelin-1 (ET-1) and vascular endothelial growth factor (VEGF) and the role of hemeoxygenase-1 (HO-1)” (GS Di Marco, 2009)
Innovative Medizinische Forschung (IMF – MFM): “Anti-angiogenic effects of Angiotensinogen” (M Brand, 2007)